| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:07:52 -0700 |
| HMDB ID |
HMDB00079 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Dihydrothymine |
| Description |
Dihydrothymine is an intermediate breakdown product of thymine. Dihydropyrimidine dehydrogenase catalyzes the reduction of thymine to 5, 6-dihydrothymine then dihydropyrimidinase hydrolyzes 5, 6-dihydrothymine to N-carbamyl-b-alanine. Finally, beta-ureidopropionase catalyzes the conversion of N-carbamyl-b-alanine to beta-alanine. Patients with dihydropyrimidinase deficiency exhibit highly increased concentrations of 5, 6-dihydrouracil and 5, 6-dihydrothymine and moderately increased concentrations of uracil and thymine can be detected in urine. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 5,6-Dihydro-5-methyluracil
- 5,6-Dihydrothymine
- 5-Methyl-5,6-dihydrouracil
- 5-Methyl-Hydrouracil
- 5-Methyldihydropyrimidine-2,4(1H,3H)-dione
- Dihydro-5-methyl-2,4(1H,3H)-Pyrimidinedione
- Dihydrothymine
|
| Chemical Formula |
C5H8N2O2 |
| Average Molecular Weight |
128.1292 |
| Monoisotopic Molecular Weight |
128.05857751 |
| IUPAC Name |
5-methyl-1,3-diazinane-2,4-dione |
| Traditional IUPAC Name |
dihydrothymine |
| CAS Registry Number |
696-04-8 |
| SMILES |
CC1CNC(=O)NC1=O |
| InChI Identifier |
InChI=1S/C5H8N2O2/c1-3-2-6-5(9)7-4(3)8/h3H,2H2,1H3,(H2,6,7,8,9) |
| InChI Key |
NBAKTGXDIBVZOO-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aliphatic Heteromonocyclic Compounds |
| Class |
Diazines |
| Sub Class |
Pyrimidines and Pyrimidine Derivatives |
| Other Descriptors |
- Aliphatic Heteromonocyclic Compounds
- Pyrimidines and Pyrimidine Derivatives
- Ureides
- a base derivative(Cyc)
- a pyrimidine-related compound(Cyc)
- pyrimidone(ChEBI)
|
| Substituents |
- Carboxamide Group
- Carboxylic Acid Imide, N Unsubstituted
- Urea
|
| Direct Parent |
Pyrimidones |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Expected and not Quantified |
|
Not Applicable |
Not Available |
Not Available |
Normal |
Inferred from detection in urine
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
1.1 +/- 0.3 uM |
Adult (>18 years old) |
Not Specified |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.4 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
5.00 (0.00-10.00) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.4 (1.3-4.4) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
0.40 (0.17-0.64) umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
0.57 (0.21-0.94) umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.0 - 24.0 uM |
Not Specified |
Both |
Dihydropyrimidinase deficiency |
Not Available |
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
4.0 - 5.2 uM |
Adult (>18 years old) |
Not Specified |
Beta-ureidopropionase deficiency |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Dihydropyrimidinase deficiency |
- van Kuilenburg AB, Meijer J, Dobritzsch D, Meinsma R, Duran M, Lohkamp B, Zoetekouw L, Abeling NG, van Tinteren HL, Bosch AM: Clinical, biochemical and genetic findings in two siblings with a dihydropyrimidinase deficiency. Mol Genet Metab. 2007 Jun;91(2):157-64. Epub 2007 Mar 26.
Pubmed: 17383919
|
| Beta-ureidopropionase deficiency |
- van Kuilenburg AB, Meinsma R, Beke E, Assmann B, Ribes A, Lorente I, Busch R, Mayatepek E, Abeling NG, van Cruchten A, Stroomer AE, van Lenthe H, Zoetekouw L, Kulik W, Hoffmann GF, Voit T, Wevers RA, Rutsch F, van Gennip AH: beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. Hum Mol Genet. 2004 Nov 15;13(22):2793-801. Epub 2004 Sep 22.
Pubmed: 15385443
|
|
| Associated OMIM IDs |
- 613161
(Beta-ureidopropionase deficiency)
- 222748
(Dihydropyrimidinase deficiency)
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021892 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
84456  |
| KEGG Compound ID |
C00906  |
| BioCyc ID |
DIHYDRO-THYMINE  |
| BiGG ID |
36347  |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB00079  |
| Metagene Link |
HMDB00079  |
| METLIN ID |
5135  |
| PubChem Compound |
93556  |
| PDB ID |
Not Available |
| ChEBI ID |
27468  |
| References |
| Synthesis Reference |
Yamane, Tetsuo; Wyluda, Benjamin J.; Shulman, Robert G. Dihydrothymine from ultraviolet-irradiated DNA. Proceedings of the National Academy of Sciences of the United States of America (1967), 58(2), 439-42. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Assmann B, Hoffmann GF, Wagner L, Brautigam C, Seyberth HW, Duran M, Van Kuilenburg AB, Wevers R, Van Gennip AH: Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation? J Inherit Metab Dis. 1997 Sep;20(5):681-8.
Pubmed: 9323563
- van Lenthe H, van Kuilenburg AB, Ito T, Bootsma AH, van Cruchten A, Wada Y, van Gennip AH: Defects in pyrimidine degradation identified by HPLC-electrospray tandem mass spectrometry of urine specimens or urine-soaked filter paper strips. Clin Chem. 2000 Dec;46(12):1916-22.
Pubmed: 11106323
- Hofmann U, Schwab M, Seefried S, Marx C, Zanger UM, Eichelbaum M, Murdter TE: Sensitive method for the quantification of urinary pyrimidine metabolites in healthy adults by gas chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):371-80.
Pubmed: 12798197
- Rosenbaum K, Jahnke K, Curti B, Hagen WR, Schnackerz KD, Vanoni MA: Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes. Biochemistry. 1998 Dec 15;37(50):17598-609.
Pubmed: 9860876
- Sumi S, Kidouchi K, Kondou M, Hayashi K, Dobashi K, Kouwaki M, Togari H, Wada Y: Possible prediction of adverse reactions to fluorouracil by the measurement of urinary dihydrothymine and thymine. Int J Mol Med. 1998 Oct;2(4):477-482.
Pubmed: 9857238
- Van Kuilenburg AB, Van Lenthe H, Van Gennip AH: Identification and tissue-specific expression of a NADH-dependent activity of dihydropyrimidine dehydrogenase in man. Anticancer Res. 1996 Jan-Feb;16(1):389-94.
Pubmed: 8615641
- Kobayashi K, Sumi S, Kidouchi K, Mizuno I, Mohri N, Fukui T, Akamo Y, Takeyama H, Manabe T: [A case of gastric cancer with decreased dihydropyrimidine dehydrogenase activity] Gan To Kagaku Ryoho. 1998 Jul;25(8):1217-9.
Pubmed: 9679586
- Sumi S, Imaeda M, Kidouchi K, Ohba S, Hamajima N, Kodama K, Togari H, Wada Y: Population and family studies of dihydropyrimidinuria: prevalence, inheritance mode, and risk of fluorouracil toxicity. Am J Med Genet. 1998 Jul 24;78(4):336-40.
Pubmed: 9714435
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
|